CWS Market Review – February 25, 2011
In last week’s e-letter, I said I was concerned that the stock market’s rally looked overextended. Unfortunately, I was spot on. On Tuesday, Wall Street gave us our biggest one-day sell-off in six months-and that was just the beginning. The market continued to fall on Wednesday and Thursday. The $VIX, which is the Volatility Index, spiked to its highest level since November.
What’s also troubling is that oil has soared due to the political unrest in the Middle East. If you’re a Middle Eastern tyrant, your job security ain’t looking too hot right about now. The problem with higher gasoline prices is that it almost acts like a regressive tax on American consumers. The major difference is that those funds generally leave the country instead of heading towards the U.S. Treasury.
I continue to believe that stock returns won’t be very impressive this spring. A flattish market is the safest assumption. For the entire year, I continue to like the market a lot. Profits have been very strong and the rout in the bond market has cooled off. The yield on the 10-year Treasury is back below 3.5% which isn’t much competition to a market that just completed its fastest double since the Depression. I think it’s very possible that the S&P 500 can break 1,500 before the year is over. Make no mistake; that’s a very aggressive forecast. On top of that, our stocks are ahead of the market for the year so far, and I expect that lead to grow. We already have five double-digit winners on the Buy List.
Today I want to revisit an issue I discussed before: the relative downturn of cyclical stocks. I thought we had already seen the peak in cyclicals a few weeks ago, but it turned out to be a head-fake as cyclicals gave us one last surge. Since February 11th, cyclicals have been trailing the market and they’ve faced a lot of pain this week. Since last Thursday, the Morgan Stanley Cyclical Index ($CYC) is down over 6.2%. That’s equivalent to 750 points on the Dow which is about three times what the Dow has actually lost.
You may be curious as to why I pay so much attention to the relative performance of cyclical stocks. The reason is it tells us a lot of what the market is thinking. Also, cyclical peaks and valleys tend to be very pronounced. Once a trend is established, it’s often quite strong and will last for a few years. If you want an example, the Dow would have to be around 24,000 today if it had kept pace with the CYC since March 2009.
Many of the stocks on the Buy List are counter-cyclicals (also known as “defensive stocks”). These are stocks from sectors like healthcare, utilities and consumer staples. The common characteristic is that defensive stocks don’t see their businesses suffer much during an economic downturn. Consumers don’t cut back as much on their food or medical costs (or cigarettes-thank you, RAI). I think it’s very likely that these sectors are due for a long stretch of outperformance.
The other fact to keep in mind is that cyclical stocks tend to outperform the market when the market itself is rising. This is sort of a double-whammy effect and that’s exactly what we’ve seen over the past two years. Conversely, cyclicals tend to underperform during falling markets, though this is more of a generality than an iron rule. That’s why I think defensive stocks will prosper this year even though the market will also do well, but you certainly shouldn’t expect the S&P 500 to double again over the next two years.
Now let’s look at some individual stocks. One of our healthcare stocks, Medtronic ($MDT), reported earnings this week. In last week’s issue of CWS Market Review, I said to expect earnings of 86 cents per share which was two cents more than Wall Street’s consensus. Once again, I was spot on.
My take is that Medtronic is a very good buy, but I should warn you that the company is currently working its way through a rough patch. Stocks that turn out to be good buys are often seen as damaged goods on Wall Street. That’s why their share price is low and that’s how Medtronic looks today. The company lowered its full-year guidance twice last year. No doubt, that’s spooked a lot of folks. Still, the company is making a good profit and the lowered guidance isn’t as bad as it may appear.
With the earnings report, Medtronic narrowed its full-year guidance to a range between $3.38 and $3.40 per share. Since MDT’s fiscal year ends in April, that’s equivalent to a Q4 forecast of 91 to 93 cents per share. (My take: That’s probably a wee bit too low.)
Let’s bust out some math: In August MDT lowered its 2011 EPS guidance to a range of $3.40 to $3.48 from $3.45 to $3.55. Then in November, it was brought down to $3.38 to $3.44; and now it’s $3.38 to $3.40. This means that MDT will probably wind up missing the low end of the original forecast by a few pennies, yet the stock has badly lagged the market. Medtronic is a strong buy below $40 per share.
Outside of Medtronic, some other Buy List stocks that look good right now include Moog ($MOG-A), Stryker (SYK) and Oracle ($ORCL). Oracle is due to report earnings in about a month and I think we’ll see some very strong numbers. I also want to note that shares of Ford ($F) continue to plunge lower. Ford is a risky stock but it’s one the few cyclicals I like.
Next week will be a fairly quiet time for earnings news, although Leucadia ($LUK) may report. The big news event will occur next Friday when the Labor Department releases the jobs report for February. Almost all of the jobs reports have been terrible, so it will be interesting to see if there’s a break in that trend.
I’m also keeping a close eye on the market’s 50-day moving average. This is one of those simple rules that has a pretty good track record. As long as the S&P 500 trades above its average close for the previous 50 days, the market tends to do well. When it breaks below the 50-DMA, the index does much worse. It’s that simple, but the 50-DMA has a much better track record than folks who are paid much more than it have. Despite the recent sell-off, we’re still holding just above the 50-DMA. This could change very soon.
That’s all for now. Be sure to keep visiting the blog for daily updates. I’ll have more market analysis for you in the next issue of CWS Market Review!
Best – Eddy
Posted by Eddy Elfenbein on February 25th, 2011 at 7:47 am
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
- Tweets by @EddyElfenbein
-
Archives
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005